Biotech · Private company · Baltimore, MD, US
Immunoblue, LLC
Track this companyFree. Adds Immunoblue, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards3
- Engineered Glioblastoma-specific T cells using Immunostimulatory Photothermal NanoparticlesFiscal year 2026 · $1.1MNIH RePORTER 5R42CA287488-03 · fetched Nov 12, 2026
- Engineered Glioblastoma-specific T cells using Immunostimulatory Photothermal NanoparticlesFiscal year 2025 · $1.1MNIH RePORTER 2R42CA287488-02 · fetched Nov 12, 2026
- Engineered Glioblastoma-specific T cells using Immunostimulatory Photothermal NanoparticlesFiscal year 2024 · $399.7KNIH RePORTER 1R41CA287488-01A1 · fetched Nov 12, 2026